Back
ESC Professional Premium Access

Exercise ECG and myocardial perfusion SPECT show high prognostic value up to four years after examination

Session: Risk stratification and treatment options in chronic coronary syndrome
Topic: Epidemiology, Prognosis, Outcome
Speaker: Mr M. Kraen (Malmo, SE)
Event: ESC Congress 2023

Congress Presentation

About the speaker

Mr Morten Kraen

Lund University, Malmo (Sweden)
0 follower

7 more presentations in this session

Treatment of microvascular angina with the coronary sinus reducer: a first experience

Speaker: Doctor E. Gnan (Milan, IT)

Access
Abstract
Slides
Video
Thumbnail

Diagnostic performance of machine learning on 12-lead electrocardiogram for predicting multi-vessel coronary vasospastic angina

Speaker: Doctor Y. Misu (Yokohama, JP)

Access
Abstract
Slides
Video
Thumbnail

The efficacy of coronary sinus reduction in refractory angina: A meta-analysis

Speaker: Doctor P. Theofilis (Athens, GR)

Access
Abstract
Slides
Video
Thumbnail

Changes in myocardial perfusion after coronary sinus reducer implantation for refractory angina - assessment using fully automated quantitative stress perfusion cardiac MRI

Speaker: Doctor K. Cheng (London, GB)

Access
Abstract
Slides
Video
Thumbnail

Angiogenic gene therapy for refractory angina: results of the epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (EXACT) phase 2 trial

Speaker: Professor T. Povsic (Durham, US)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Risk stratification and treatment options in chronic coronary syndrome

Speakers: Mr M. Kraen, Doctor E. Gnan, Doctor Y. Misu, Doctor P. Theofilis, Doctor K. Cheng...
Access
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb